Metraipolis › archive › dc_ca3a1780a052

Clinically advanced NLRP3 inhibitor modulates microglial transcriptome and alleviates α-synuclein-induced progression of parkinsonism — Europe PMC PMID:41620763

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41620763
DOI
10.1186/s12974-[numero omesso]-3
License (as archived)
solo-consultazione
Archived
2026-11-06T09:32:38.271Z
SHA-256 of the archived text
97883fb0c311b54e0f9a32be724dfd9ab9870f0b937f51a937137c147404d111
Stable URL of this page
https://metraipolis.com/documento/dc_ca3a1780a052

How to cite

Clinically advanced NLRP3 inhibitor modulates microglial transcriptome and alleviates α-synuclein-induced progression of parkinsonism — Europe PMC PMID:41620763 — Europe PMC (en), https://europepmc.org/article/MED/41620763 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ca3a1780a052 (Metraipolis archive dc_ca3a1780a052, sha256 97883fb0c311b54e0f9a32be724dfd9ab9870f0b937f51a937137c147404d111)
BibTeX
@misc{dcca3a1780a052,
  title = {Clinically advanced NLRP3 inhibitor modulates microglial transcriptome and alleviates α-synuclein-induced progression of parkinsonism — Europe PMC PMID:41620763},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41620763},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ca3a1780a052; sha256 97883fb0c311b54e0f9a32be724dfd9ab9870f0b937f51a937137c147404d111},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41620763. Agents can read the archived copy with the MCP tool read_document.